Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A compassionate study of MaaT013 in patients with acute Graft-versus-Host-Disease after receiving an allogeneic Hematopoietic Stem Cell Transplantation to treat their hematologic malignancies

Next Previous
Search
Trial Profile

A compassionate study of MaaT013 in patients with acute Graft-versus-Host-Disease after receiving an allogeneic Hematopoietic Stem Cell Transplantation to treat their hematologic malignancies

Status: Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 04 Sep 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Maa-T-013 (Primary)
  • Indications Graft-versus-host disease
  • Focus Expanded access; Therapeutic Use

    • Most Recent Events

    • 31 Aug 2020 According to a MaaT Pharma media release, results were presented by Dr. Florent Malard, Associate Professor of Hematology at Saint-Antoine Hospital and Sorbonne University in an ePoster presentation on August 29, 2020 during the Virtual 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT).
    • 31 Aug 2020 Results presented in a MaaT Pharma Media Release.
    • 28 Aug 2020 According to a MaaT Pharma media release, data from this study will be presented at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) to be held virtually. The company will announce the results of this study through a press release on 31 Aug 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top